BOTHELL, Wash., June 4 CellCyte GeneticsCorporation's (CellCyte) (OTC Bulletin Board: CCYG) President and CEO, Gary A.Reys, will present at the 2008 San Francisco RedChip Small-Cap InvestorConference on Thursday, June 5, at 10:35 AM Pacific Daylight Time at thePalace Hotel in San Francisco. In addition, CellCyte will have a booth at theconference at which they will have a prototype demonstration of the Company'scell expansion bioreactor.
The presentation will be Web cast live with slides and archived for replayafter the presentation at:http://www.redchip.com/visibility/conferencePages/SanFran2008/conferenceMain.asp?page=webcast
About CellCyte Genetics
CellCyte Genetics Corporation is a biotechnology company engaged in thediscovery, development and commercialization of stem cell enabling therapeuticproducts. CellCyte is developing products to allow more efficient delivery andincreased retention of adult stem cells to diseased organs, such as the heart.The goal of these therapies is to increase the number of stem cells deliveredto a damaged organ, thereby markedly increasing organ healing and functionalrestoration. The Company's lead product in development, CCG-TH30, is designedto send autologous bone marrow-derived (adult) stem cells to the heart ofpatients after a heart attack.CellCyte Genetics | 1725 220th Street SE | Bothell | Washington | 98021 | USA For further information see: http://www.cellcyte.com. Symbol: OTCBB - CCYG; Frankfurt/Berlin Symbol - LK6 WKN. No.: A0MLCV.
SOURCE CellCyte Genetics Corporation